VEGFA and breast neoplasm: The effect of ERO1 loss on VEGF impairment results in breast tumor and hepatocarcinoma cells with a lower pro-angiogenic potential [65], metastatic breast tumors with reduced blood vessels in the primary site and less lung metastases [56,70].